Pfizer to donate all proceeds from Russia to Ukraine for humanitarian aid

0
13
New York (USA): Pfizer said on Monday that it would donate all profits of its Russian subsidiary to provide humanitarian aid to the people of Ukraine.

“Today we are announcing that, effective immediately, Pfizer will donate all profits of our Russian subsidiary to causes that provide direct humanitarian assistance to the people of Ukraine. This will complement all other recently announced donations from Pfizer to Ukraine. in addition to,” the statement read by the company.

Pfizer imposed new sanctions on Russia such as no longer starting new clinical trials in Russia and stopping the recruitment of new patients into the company’s ongoing clinical trials in the country.

Describing Russia’s war in Ukraine as brutal, the company said, “Pfizer stands with the integrated global community in the public, private and civil society sectors in protesting against the Russian war in Ukraine and the brutal situation it has created.”

Pfizer will work with the FDA and other regulators to move all ongoing clinical trials to alternative sites outside of Russia. “In line with our commitment to put patients first, we will continue to provide essential drugs to patients already enrolled in clinical trials,” it noted.

This will further close all planned investments with local suppliers intended to build manufacturing capacity in Russia. “Ultimately, while Pfizer does not own or operate any manufacturing sites in Russia, we will halt all planned investments with local suppliers aimed at building manufacturing capacity in the country.”

The company also said that it would continue to maintain supply of drugs to Russia, however, emphasized that this does not mean that it will continue to do business in Russia as usual. The US multinational pharmaceutical company is concerned that a voluntary halt in the flow of our drugs to Russia would be a direct violation of the company’s fundamental principle of putting patients first.

“Ending the delivery of drugs, including cancer or cardiovascular therapy, would result in significant patient suffering and potential loss of life, particularly among children and the elderly,” the statement said.

“However, maintaining the supply of drugs to Russia does not mean that we will continue to do business in Russia as usual… These decisions align with our patient-first values ​​and ensure that the products received from Russia Every dollar gain will strengthen Ukraine and its people. The company condemned Russia, saying they continue to bravely defend their nation and independence from this unprovoked and unjustified attack.(ANI)

First published:14 March 2022, 10:06 pm

Leave a Reply